Therapeutic Area Market Research Reports & Industry Analysis
Therapeutic areas include Cardiology/Vascular Diseases, Dental and Oral Health, Dermatology, Devices, Endocrinology, Family Medicine, Gastroenterology, Genetic Disease, Healthy Volunteers, Hematology, Hepatology, Immunology, Infections and Infectious Diseases, Internal Medicine, Musculoskeletal, Nephrology, Neurology, Nutrition and Weight Loss, Obstetrics/Gynecology, Oncology, Ophthalmology, Orthopedics/Orthopedic Surgery, Otolaryngology, Pediatrics/Neonatology, Pharmacology/Toxicology, Podiatry, Psychiatry/Psychology, Pulmonary/Respiratory Diseases, Rheumatology, Sleep, Trauma, Urology, and Vaccines.
Reports in these categories will contain statistics of prevalence and growth concerning therapeutic area diseases for which there are product reviews, market size, and share for products that are used in pharmaceutical treatment or equipment that used in surgical treatment of the therapeutic area.
Therapeutic Area Industry Research & Market Reports
-
Eye Allergy Therapeutics
... by 2030, growing at a CAGR of 5.4% over the analysis period 2023-2030. Antihistamines, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$2.2 Billion by the ... Read More
-
Neuroprosthetics
... of 12.0% over the analysis period 2023-2030. Motor Neuron Disorders Application, one of the segments analyzed in the report, is expected to record a 13.5% CAGR and reach US$15.8 Billion by the end of the ... Read More
-
Spinal Trauma Devices
... by 2030, growing at a CAGR of 5.6% over the analysis period 2023-2030. Internal Fixation Devices, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$4.9 Billion ... Read More
-
Spinal Muscular Atrophy
... by 2030, growing at a CAGR of 12.3% over the analysis period 2023-2030. Type 1 Spinal Muscular Atrophy, one of the segments analyzed in the report, is expected to record a 12.9% CAGR and reach ... Read More
-
Addiction Treatment
... at a CAGR of 4.8% over the analysis period 2023-2030. Alcohol Addiction Treatment, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$3.0 Billion by the end ... Read More
-
Substance Abuse Treatment
... by 2030, growing at a CAGR of 7.2% over the analysis period 2023-2030. Nicotine Addiction Treatment, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$9.4 Billion ... Read More
-
Neurology Devices
... at a CAGR of 5.9% over the analysis period 2023-2030. Cerebrospinal Fluid Management Devices, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$7.1 Billion by the ... Read More
-
Ophthalmic Femtosecond Lasers
... by 2030, growing at a CAGR of 4.7% over the analysis period 2023-2030. Consumables & Accessories, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$666.4 Million ... Read More
-
Breakthrough Therapy (BT) Designation
... reach US$415.7 Billion by 2030, growing at a CAGR of 15.4% over the analysis period 2023-2030. Oncology Application, one of the segments analyzed in the report, is expected to record a 16.2% CAGR and reach ... Read More
-
Atherosclerotic Cardiovascular Disease (ASCVD) - Market Insight, Epidemiology And Market Forecast - 2034
... a full or partial extra copy of chromosome 21. This additional genetic material alters development, leading to the physical and intellectual characteristics associated with Down’s syndrome. The market size of Down’s syndrome in 2023 was ... Read More
-
Mild Cognitive Impairment - Epidemiology Forecast - 2034
... thousand cases which is further expected to increase by 2034. In the US, in 2023, ~6,978 thousand people were affected with Alzheimer disease, accounting for the highest number of cases in the 7MM. DelveInsight estimates ... Read More
-
Global Malignant Pleural Mesothelioma Market (2024 Edition): Analysis By Drug Type (Pemetrexed and Combination, Cisplatin, Carboplatin, Gemcitabine, Vinorelbine, Other Drug Types), By Route of Administration, By Distribution Channel, By Region, By Country: Market Insights and Forecast (2020-2030)
... Forecast (2020-2030) Executive Summary Azoth Analytics has released a research report titled “Global Malignant Pleural Mesothelioma Market (2024 Edition)” which provides a Pemetrexed and Combination analysis of the Global Malignant Pleural Mesothelioma industry in terms ... Read More
-
Rheumatology Therapeutics
... CAGR of 3.1% over the analysis period 2023-2030. Disease Modifying Anti-Rheumatic Drugs (DMARDs), one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$51.3 Billion by the end ... Read More
-
Small Bone and Joint Orthopedic Devices
... reach US$20.4 Billion by 2030, growing at a CAGR of 6.6% over the analysis period 2023-2030. Fracture Fixation & Replacement Systems, one of the segments analyzed in the report, is expected to record a 7.8% ... Read More
-
Aesthetic Ophthalmology Devices
... at a CAGR of 7.8% over the analysis period 2023-2030. Cosmetic Clinics End-Use, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$432.0 Million by the end ... Read More
-
Congestive Heart Failure (CHF) Treatment Devices
... reach US$37.9 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2023-2030. Implantable Cardioverter Defibrillators, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and ... Read More
-
Dental Fluoride Treatment
... at a CAGR of 5.1% over the analysis period 2023-2030. Toothpaste, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$4.2 Billion by the end of the ... Read More
-
Infectious Disease Therapeutics
... at a CAGR of 7.1% over the analysis period 2023-2030. HIV Disease Therapeutics, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$113.7 Billion by the end ... Read More
-
Intracranial Pressure (ICP) Monitoring Devices
... Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Invasive Technique, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$2.4 Billion ... Read More
-
Liver Cancer Diagnostics
... at a CAGR of 7.3% over the analysis period 2023-2030. Laboratory Tests, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$9.8 Billion by the end of ... Read More
-
Cosmetic Dentistry
... CAGR of 6.1% over the analysis period 2023-2030. Dental Systems & Equipment, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$14.2 Billion by the end of ... Read More
-
Heart Valve Repair and Replacement Devices
... the year 2023, is expected to reach US$43.1 Billion by 2030, growing at a CAGR of 16.0% over the analysis period 2023-2030. Replacement Devices Application, one of the segments analyzed in the report, is expected ... Read More
-
Non-Hodgkin Lymphoma Therapeutics
... by 2030, growing at a CAGR of 7.0% over the analysis period 2023-2030. Immunotherapy, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$10.1 Billion by the ... Read More
-
Neuroscience
... of 3.8% over the analysis period 2023-2030. Instruments Component, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$29.9 Billion by the end of the analysis period. ... Read More
-
Nocturia Drugs
... at a CAGR of 6.1% over the analysis period 2023-2030. Low Nocturnal Bladder Capacity Indication, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$3.0 Billion by ... Read More
Research Assistance
